Primary Peptides

We are a clinical stage protein manipulation company creating new therapeutics for patients worldwide. Our platform technologies consist of: - Protein-protein interaction blockade which prevents specific disease-causing proteins from interacting with each other; - Protein degradation which harnesses the body's own natural processes to destroy disease causing proteins. By adopting these approaches, we are expanding the scope of new targets for drug development and unlocking the untapped pool of targets that to date have been considered undruggable. Our goal is to develop a new generation of therapeutics for patients that currently have few options, if any, to treat their diseases effectively.